OpGen ROE 2014-2018 | OPGN

Current and historical return on equity (ROE) values for OpGen (OPGN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. OpGen ROE for the three months ending September 30, 2018 was -238.35%.
OpGen ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $-0.01B $0.00B -240.00%
2018-06-30 $-0.01B $0.01B -240.00%
2018-03-31 $-0.01B $0.01B -433.33%
2017-12-31 $-0.02B $0.00B -1500.00%
2017-09-30 $-0.02B $0.00B -1133.33%
2017-06-30 $-0.02B $-0.00B -1520.00%
2017-03-31 $-0.02B $0.00B -533.33%
2016-12-31 $-0.02B $0.00B -470.59%
2016-09-30 $-0.02B $0.00B -380.95%
2016-06-30 $-0.02B $0.01B -266.67%
2016-03-31 $-0.02B $0.00B -258.06%
2015-12-31 $-0.02B $0.01B -300.00%
2015-09-30 $-0.01B $0.01B -430.77%
2015-06-30 $-0.01B $0.01B -4400.00%
2015-03-31 $-0.01B $-0.00B 400.00%
2014-12-31 $-0.01B $-0.00B 600.00%
2014-09-30 $-0.01B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Services $0.009B $0.003B
OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $54.367B 11.24
ICON (ICLR) Ireland $7.475B 23.43
PRA Health Sciences (PRAH) United States $6.757B 27.59
Charles River Laboratories (CRL) United States $6.195B 21.72
Premier (PINC) United States $5.196B 17.63
INC Research Holdings (SYNH) United States $4.962B 20.03
HealthEquity (HQY) United States $4.229B 82.67
Teladoc (TDOC) United States $3.750B 0.00
NovoCure (NVCR) Jersey $3.296B 0.00
AMN Healthcare Services Inc (AMN) United States $2.777B 19.06
BioTelemetry (BEAT) United States $2.212B 39.06
Medpace Holdings (MEDP) United States $2.054B 25.41
IKang Healthcare (KANG) China $1.240B 61.55
Intrexon (XON) United States $1.210B 0.00
Healthways (TVTY) United States $1.107B 13.61
CareDx (CDNA) United States $1.067B 0.00
Natera (NTRA) United States $1.051B 0.00
China Cord Blood (CO) China $0.731B 20.03
Surgery Partners (SGRY) United States $0.648B 0.00
Apollo Medical Holdings (AMEH) United States $0.629B 0.00
Establishment Labs Holdings (ESTA) $0.511B 0.00
Civitas Solutions (CIVI) United States $0.472B 9.30
OncoCyte (OCX) United States $0.063B 0.00
Interpace Diagnostics (IDXG) United States $0.029B 0.00
Cancer Genetics (CGIX) United States $0.006B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.002B 0.00